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ABSTRACT
The programming of cellular networks to achieve
new biological functions depends on the develop-
ment of genetic tools that link the presence of a
molecular signal to gene-regulatory activity.
Recently, a set of engineered RNA controllers was
described that enabled predictable tuning of gene
expression in the yeast Saccharomyces cerevisiae
through directed cleavage of transcripts by an
RNase III enzyme, Rnt1p. Here, we describe a
strategy for building a new class of RNA sensing-
actuation devices based on direct integration of
RNA aptamers into a region of the Rnt1p hairpin
that modulates Rnt1p cleavage rates. We demon-
strate that ligand binding to the integrated
aptamer domain is associated with a structural
change sufficient to inhibit Rnt1p processing.
Three tuning strategies based on the incorporation
of different functional modules into the Rnt1p switch
platform were demonstrated to optimize switch
dynamics and ligand responsiveness. We further
demonstrated that these tuning modules can be im-
plemented combinatorially in a predictable manner
to further improve the regulatory response proper-
ties of the switch. The modularity and tunability of
the Rnt1p switch platform will allow for rapid opti-
mization and tailoring of this gene control device,
thus providing a useful tool for the design of
complex genetic networks in yeast.
INTRODUCTION
The ﬁeld of synthetic biology encompasses the engineering
of biological systems that exhibit new functions through
the design of synthetic gene networks. The proper
functioning of genetic networks encoding complex behav-
iors depends on the coordinated regulation of genetic re-
sponses, enzymatic activities and protein levels (1–4). As
such, the genetic programming of biological systems
depends on our ability to design genetic devices that can
detect molecular signals and link these detection events to
new types of genetic control and thus biological function.
Motivated by the versatility of sensing and actuation
functions that RNA can exhibit and the relative ease
with which RNA structures can be modeled and designed,
researchers have engineered RNA-based devices that
detect diverse molecular signals and link this information
to the regulation of gene expression events (5). RNA
devices generally couple RNA components that exhibit
sensing, actuation and information transmission activities.
By varying the regulatory RNA encoded within the
actuator component, RNA devices have been developed
that function in different organisms through a variety of
gene-regulatory mechanisms, including translation (6–10),
transcript degradation (11,12), transcriptional activation
(13) and splicing (14–16). Recently, several examples of
RNA devices that act through the modulation of RNase
III processing activities in mammalian cells have been
described (17–19). However, such regulatory strategies
have not yet been extended to RNase III enzymes in
microorganisms.
We previously developed a genetic control system based
on directing transcript cleavage through the RNase III
enzyme in the yeast Saccharomyces cerevisiae (Rnt1p),
where Rnt1p hairpin substrates are placed in the 30 un-
translated region (UTR) of the targeted gene (20). We
utilized cell-based screening strategies to develop libraries
of synthetic Rnt1p hairpins that exhibit predictable gene-
regulatory activity based on modules that are inserted
into two key regions of the hairpin—the cleavage efﬁ-
ciency box (CEB) and the binding stability box (BSB).
These studies indicated that the CEB and BSB mod-
ules function independently and can be combinatorially
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range of gene-regulatory activities (20; A.H. Babiskin and
C.D. Smolke, submitted for publication).
Here, we describe the design of a new class of RNA
devices based on the synthetic library of Rnt1p regulatory
elements, which we call an Rnt1p switch. We have
designed a strategy for coupling RNA aptamers to
Rnt1p hairpins to build RNA control systems in yeast
that exhibit integrated sensing and actuation functions.
Speciﬁcally, theophylline aptamers were integrated into
the CEB region of the Rnt1p hairpin, which plays a key
role in modulating Rnt1p cleavage rates, where binding of
the small molecule to the aptamer sequence resulted in
inhibition of cleavage activity. We demonstrated three dif-
ferent strategies for tuning the quantitative properties of
the device response curve based on the integration of dif-
ferent modules into the Rnt1p switch platform. Aptamer/
CEB, BSB and multiple switch modules were used to
modulate the EC50 value and switching activity of the
device. Finally, we demonstrated that these modules can
be implemented combinatorially in a predictable manner
to further improve the regulatory response properties of
the switch. The application of these tuning strategies
resulted in an increase of the fold-change from 1.93 to
2.47 in a single module switch and an increase from 1.93
to 5.57 when three copies of the single module switch were
implemented.
MATERIALS AND METHODS
Plasmid construction
Standard molecular biology techniques were utilized to
construct all plasmids (21). DNA synthesis was performed
by Integrated DNA Technologies (Coralville, IA, USA) or
the Protein and Nucleic Acid Facility (Stanford, CA,
USA). All enzymes, including restriction enzymes and
ligases, were obtained through New England Biolabs
(Ipswich, MA, USA) unless otherwise noted. Pfu polymer-
ase was obtained through Stratagene. Ligation products
were electroporated with a GenePulser XCell (Bio-Rad,
Hercules, CA, USA) into Escherichia coli DH10B
(Invitrogen, Carlsbad, CA), where cells harboring cloned
plasmids were maintained in Luria-Bertani media con-
taining 50mg/ml ampicillin (EMD Chemicals). Clones
were initially veriﬁed through colony PCR and restric-
tion mapping. All cloned constructs were sequence
veriﬁed by Laragen (Los Angeles, CA, USA) or Elim
Biopharmaceuticals (Hayward, CA, USA).
The construction of the Rnt1p characterization
plasmid, pCS321, and the Rnt1p expression plasmid,
pRNT1, have been previously described (20). The
plasmid map for pCS321 is available in Supplementary
Figure S1. Insertion of engineered Rnt1p substrates and
appropriate controls into the 30-UTR of a gene encoding a
yeast-enhanced green ﬂuorescent protein (yEGFP3)i n
pCS321 was performed through either digestion with
appropriate restriction endonucleases and ligation-
mediated cloning or homologous recombination-mediated
gap-repair during transformation into S. cerevisiae strain
W303 (MATa, his3-11, 15 trp1-1 leu2-3 ura3-1 ade2-1)
through standard lithium acetate procedures (22).
The single module Rnt1p switch (RS), its mutant tetraloop
control, the BSB variants and the theophylline aptamer
variant RS-theo3 with its own BSB variants were
ampliﬁed for insertion with both techniques using the
forward and reverse primers RS_fwd (50 ATGGTATGG
ATGAATTGTACAAATAAAGAGCCTAGGAAACA
AACAAACTTGATGCCCTTGG) and RS_rev (50 AAA
TTCGCTTATTTAGAAGTGGCGCGCCCTCTCGAG
TTTTTATTTTTCTTTTTACGATGCTGGTATC), re-
spectively. Two of the theophylline aptamer variants
required individually designed primers: RSnt_fwd (50 AT
GGTATGGATGAATTGTACAAATAAAGAGCCTA
GGAAACAAACAAACTTGATGCCATTGG) and
RS_rev for RSnt; and RS-theo2_fwd (50 ATGGTATGG
ATGAATTGTACAAATAAAGAGCCTAGGAAACA
AACAAACTTGGCCCTTGGCA) and RS-theo2_rev
(50 AAATTCGCTTATTTAGAAGTGGCGCGCCCTC
TCGAGTTTTTATTTTTCTTTTTACGGCTGGTATC
CA) for RS-theo2. A second switch module was ampliﬁed
for insertion using the forward and reverse primers
RSx2_fwd (50 GTGCTCGAGAAACAAACAAACTTG
ATGCCCTTGGCA) and RSx2_rev (50 CAGCTCGAG
TTTTTATTTTTCTTTTTACGATGCTGGTATCCAG
ATG). A third switch module was ampliﬁed for insertion
using the forward and reverse primers RSx3_fwd (5 GTG
CCTAGGAAACAAACAAACTTGATGCCCTTGGCA)
and RSx3_rev (50 CAGCCTAGGTTTTTATTTTTCTTT
TTACGATGCTGGTATCCAGATG). In the case of di-
gestion and ligation, the PCR products were digested with
the unique restriction sites AvrII and/or XhoI, which are
located 3 nts downstream of the yEGFP3 stop codon and
upstream of the ADH1 terminator. Following construc-
tion and sequence veriﬁcation of the desired vectors, 100–
500ng of each plasmid was transformed into strain W303.
In the case of gap-repair, 250–500ng of the PCR product
and 100ng of plasmid digested with AvrII and XhoI were
transformed into the yeast strain. All yeast strains harbor-
ing cloned plasmids were maintained on synthetic
complete (SC) media with an uracil dropout solution
and 2% dextrose at 30 C. A table of primers and
template sequences used for each switch module is
provided in Supplementary Table S1.
Rnt1p substrate characterization assays
Saccharomyces cerevisiae cells harboring pCS321-based
plasmids were grown on SC media with an uracil
dropout solution and the appropriate sugars (2% rafﬁn-
ose, 1% sucrose) overnight at 30 C. The cells were
back-diluted the following morning into a 4.3ml combin-
ation of SC media and 25mM theophylline dissolved
directly into the same SC media to an optical density at
600nm (OD600) of 0.1 ( 200ml) and grown again at 30 C.
The theophylline solution and SC media were mixed to
achieve the appropriate concentration of theophylline
(0–5mM) in the test tube at 5ml. After 1h, the test tube
volume was brought up the ﬁnal volume of 5ml by adding
0.5ml of 20% galactose (2% ﬁnal concentration) for in-
duction or water (non-induced control) to the cell cultures.
5300 Nucleic Acids Research, 2011,Vol.39, No. 12The cells were grown for another 4.5h before measuring
the ﬂuorescence levels.
Fluorescence quantiﬁcation
On the Quanta ﬂow cytometer (Beckman Coulter,
Fullerton, CA, USA), the distribution of GFP ﬂuores-
cence was measured with the following settings: 488nm
laser line, 525nm band-pass ﬁlter and photomultiplier
tube setting of 5.83 (pCS321-based) or 4.50 (pCS1585-
based). Data were collected under low ﬂow rates until
5000 viable cell counts were collected. A non-induced
cell population was used to set a gate to represent GFP-
negative and GFP-positive populations. Final data values
are reported as the average of the median GFP-positive
ﬂuorescence from three independently-grown samples and
normalized to a construct baring no module inserts (‘no
insert’) at the same theophylline concentration. Standard
error is determined from the standard deviation of the
triplicate samples.
Quantiﬁcation of cellular transcript levels
Total RNA from S. cerevisiae was collected by a standard
hot acid phenol extraction method (23) and followed by
DNase I (New England Biolabs) treatment to remove
residual plasmid DNA according to manufacturer’s in-
structions. cDNA was synthesized from 5mg of total
RNA with gene-speciﬁc primers for yEGFP3 and ACT1
(24) (rnt1p_rtpcr_rev2 and ACT1_rtpcr_rev, respectively)
and SuperScript III Reverse Transcriptase (Invitrogen)
according to manufacturer’s instructions. The forward
and reverse primers for yEGFP3 quantiﬁcation are
rnt1p_rtpcr_fwd2 (50 CGGTGAAGGTGAAGGTGATG
CTACT) and rnt1p_rtpcr_rev2 (50 GCTCTGGTCTTGT
AGTTACCGTCATCTTTG), respectively. The forward
and reverse primers for ACT1 quantiﬁcation are ACT1_
rtpcr_fwd (50 GGCATCATACCTTCTACAACGAAT)
and ACT1_rtpcr_rev (50 GGAATCCAAAACAATACC
AGTAGTTCTA), respectively. Relative transcript levels
were quantiﬁed in triplicate from three identical reactions
from the cDNA samples by using an appropriate primer
set and iQ SYBR Green Supermix (Bio-Rad, Hercules,
CA, USA) on an iCycler iQ quantitative real-time PCR
(qRT-PCR) machine (Bio-Rad) according to the manufac-
turer’s instructions. For each run, a standard curve was
generated for yEGFP3 and a house-keeping gene, ACT1,
using a dilution series for a control representing no inser-
tion of an Rnt1p substrate. Relative yEGFP3 and ACT1
levels were ﬁrst individually determined for each sample
and then the yEGFP3 values were normalized by their
corresponding ACT1 values.
In vitro transcription of Rnt1p substrates
Rnt1p switches were PCR-ampliﬁed to include an
upstream T7 promoter site using forward and reverse
primers Rnt1p_col-T7_fwd_prmr (50 TTCTAATACGAC
TCACTATAGGATGGTATGGATGAATTGTACAAA
TAAAGCCTA) and Rnt1p_col-T7_rev_prmr (50 AAATT
CGCTTATTTAGAAGTGGCGC), respectively. About
500ng of PCR product was transcribed with T7 RNA
Polymerase (New England Biolabs) in the presence and
absence of a-P
32-GTP. The 25ml reaction consisted of
the following components: 1  RNA Pol Reaction Buffer
(New England Biolabs), 3mM rATP, 3mM rCTP, 3mM
rUTP, 0.3mM rGFP, 1ml RNaseOUT (Invitrogen),
10mM MgCl2, 2mM DTT, 1ml T7 Polymerase and
0.5mCi a-P
32-GTP. Unincorporated nucleotides were
removed from the reactions by running the samples
through NucAway Spin Columns (Ambion, Austin, TX,
USA) according to the manufacturer’s instructions.
Rnt1p expression and puriﬁcation
The pRNT1 plasmid was transformed into E. coli strain
BL21 using the Z-competent E. coli Transformation Kit
and Buffer Set (Zymo Research, Orange, CA, USA) ac-
cording to manufacturer’s instructions. Rnt1p was col-
lected as a protein extract as previously described (25).
Brieﬂy, an overnight culture of BL21 cells harboring
pRNT1 was back-diluted to an OD600 of 0.5. Once the
culture reached an OD600 of 1.1–1.4, it was induced with
1mM IPTG and grown for an additional 3 h. The cells
were centrifuged at 2500g for 12min at 4 C and the re-
sulting cell pellet was frozen in a  80 C freezer. After
weighing the frozen cell pellet, the cells were resuspended
in 4ml Ni2+ buffer [25% (v/v) glycerol, 1 M NaCl, 30mM
Tris pH 8.0] per gram of harvested cells. The resuspension
was sonicated (Heat Systems-Ultrasonics, Inc.) twice with
the following settings: 2 30s, output control 5 and 50%
duty cycle. Cellular debris was removed by centrifugation
at 20000g for 30min at 4 C and the supernatant was
ﬁltered through a 0.2mm pore size Acrodisc 25mm
syringe ﬁlter (Pall Life Sciences, Ann Arbor, MI, USA).
Rnt1p was puriﬁed from the resulting supernatant with
one 1ml HisTrap HP column (GE Healthcare) on an
AKTA fast protein liquid chromatography (FPLC)
machine (GE Healthcare). Elution of the protein was per-
formed with an imidazole concentration of 150mM in
Ni2+ buffer and the protein was collected in six-ml frac-
tions. Protein puriﬁcation was conﬁrmed by analyzing an
aliquot of each fraction on a SDS–PAGE gel (NuPAGE
4–12% Bis–Tris Gel, Invitrogen) and protein function was
conﬁrmed by incubating an aliquot of each fraction with a
control Rnt1p substrate and analyzing the resulting
cleavage products on an 8% denaturing polyacrylamide
gel. Positive fractions were pooled and concentrated to
<3ml volume using a Centricon Centrifugal Filter
Device (10000 MWCO; Millipore) according to the manu-
facturer’s instructions. The concentrated protein was then
injected into a Slide-A-Lyzer Dialysis Cassette (10000
MWCO; Pierce Biotechnology) and buffer-exchanged
twice with Rnt1p Storage Buffer [50% (v/v) glycerol,
0.5M KCl, 30mM Tris pH 8.0, 0.1M DTT, 0.1M
EDTA] at 4 C. The ﬁrst buffer exchange took place for
4h and the second buffer exchange occurred overnight.
The puriﬁed Rnt1p was stored in aliquots at  20 C.
In vitro Rnt1p substrate cleavage assay
Cleavage assays were performed on Rnt1p substrates as
previously described (25,26). Brieﬂy, a 10ml mixture of
RNA and Rnt1p were incubated at 30 C for 30min in
Rnt1p reaction buffer [30 mM Tris (pH 7.5), 150mM
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0.1mM EDTA (pH 7.5)] in the presence or absence of
10mM theophylline. The RNA concentration was
0.05mM and the Rnt1p concentration was 20.7mM. The
cleavage reaction products were separated on an 8% dena-
turing polyacrylamide gel run at 35W for 30min. Gels
were transferred to ﬁlter paper and analyzed for relative
substrate and product levels through phosphorimaging
analysis on a FX Molecular Imager (Bio-Rad).
RESULTS
Design of a ligand-responsive RNA switch based on Rnt1p
processing
We set out to utilize the synthetic Rnt1p genetic control
elements developed in early work from our laboratory in
the design of a new class of RNA devices based on the
modulation of Rnt1p processing, called an Rnt1p switch.
The ﬁrst step in building an integrated RNA device
platform is identifying a physical coupling strategy
between the sensor (i.e., aptamer) and actuator (i.e.,
Rnt1p hairpin) components that maintains the activity
of each component, but allows ligand binding to the
sensor to modify the activity of the actuator. Rnt1p sub-
strates adopt hairpin structures that contain three critical
regions for enzyme binding and processing: the initial
binding and positioning box (IBPB), comprising an
AGNN tetraloop; the BSB, comprising the base-paired
region immediately below the tetraloop; and the CEB,
comprising the nucleotides adjacent to the two cleavage
sites (27) (Figure 1A). Rnt1p initially binds to the
tetraloop (the IBPB) and the interaction is stabilized by
the BSB. The enzyme then cleaves the hairpin at two lo-
cations within the CEB: between the 14th and 15th nts
upstream of the tetraloop and the 16th and 17th nts down-
stream of the tetraloop. While the CEB has no structural
or sequence requirements, the BSB and IBPB have more
rigid sequence and structural requirements (28).
Therefore, we identiﬁed the CEB as a possible region of
the Rnt1p hairpin where the integration of aptamer se-
quences may not disrupt enzyme binding and processing.
We designed an Rnt1p switch platform based on dir-
ect replacement of the CEB with an aptamer sequence
(Figure 1A). Ligand binding in the CEB can inhibit
Rnt1p cleavage by inducing secondary or tertiary struc-
tural changes in the region that Rnt1p is unable to process
effectively or by sequestering the CEB nucleotides. The
Rnt1p switch is located in the 30-UTR of a target tran-
script, where it acts to modulate the stability of that tran-
script (Figure 1B). Speciﬁcally, in the absence of ligand the
hairpin is processed by Rnt1p, resulting in transcript de-
stabilization and a decrease in gene expression. However,
ligand binding at the integrated aptamer component will
result in inhibition of Rnt1p processing of the hairpin
structure, resulting in transcript stabilization and an
increase in expression. Thus, the Rnt1p switch acts as a
gene expression ‘ON’ switch, where gene expression is
expected to increase with increasing ligand concentration.
In addition, A-rich spacer sequences were placed around
the device to more readily enable the extension of the
system to the integration of multiple devices in the
30-UTR (Figure 1A).
The theophylline aptamer  TCT-4 (29) was selected for
the initial development of the Rnt1p switch platform due
to this sequence having the highest reported afﬁnity for
the small molecule. However, the placement of this
aptamer in the previously characterized Rnt1p substrate
R31-27 (28), which is the same base hairpin that was used
in the development of the Rnt1p cleavage library (20),
resulted in the disruption of effective Rnt1p cleavage of
the hairpin in the absence of ligand (data not shown). To
lower the baseline of the ‘OFF’ state and thus provide a
greater potential switching range, we utilized a different
Rnt1p base hairpin in the switch design that had been
previously reported to have the highest rate of Rnt1p pro-
cessing in vitro (R31L-3B4Inv) (27). For all experiments,
the highest external theophylline concentration applied to
the yeast cells was 5mM. At concentrations >10 mM,
theophylline begins to become toxic to yeast and the reli-
ability of the data decreases. All ligand titration data were
ﬁt to a simple binding model with Prism 5 (GraphPad) as:
YðtÞ¼b+
ðM   bÞ
 t
EC50+t
where Y represents the normalized gene expression data
for a given theophylline concentration (t), b represents the
amount of gene expression in the absence of theophylline
and M is the theoretical maximal ‘ON’ state determined
by the model. The value of b was determined experimen-
tally and not ﬁt in the non-linear regression. The regula-
tory range of the switch is characterized by two measures,
the fold-change, determined as the ratio of the ‘ON’ state
to the ‘OFF’ state, and the dynamic range, determined as
the difference between the ‘ON’ and the ‘OFF’ states,
where the ‘OFF’ and ‘ON’ states are deﬁned as the
value of Y (t) at theophylline concentrations of 0 and
5mM, respectively. The responsiveness of the switch was
determined as the EC50 value of the dose-response curve
(reported in terms of extracellular theophylline concentra-
tion). M gives a measure of the regulatory range of the
switch in the case where the ligand is not cytotoxic at
concentrations >5mM. The theoretical fold-change and
dynamic range based on the measured values of b and
the model-calculated parameter M are reported for all
switches in Supplementary Table S2.
We placed the theophylline aptamer in several locations
within the CEB to screen for the most effective aptamer
integration site (Supplementary Figure S2). One integra-
tion site location resulted in a functioning RNA switch
(RS-theo1-B00), which retained the ability to be effectively
cleaved by Rnt1p in the ‘OFF’ state and exhibited theo-
phylline dependent increases in target gene expression
levels (Figure 1C). In the switch naming system, the
‘theo1’ indicates the identity of the integrated aptamer
( TCT-4 aptamer) and ‘B00’ indicates the identity of
the BSB module contained in R31L-3B4Inv, which is the
same as the BSB module used in the development of the
cleavage library (20). We refer to the parent Rnt1p switch
RS-theo1-B00 as RS, and for other switches we will only
indicate modules different than the parent switch for
5302 Nucleic Acids Research, 2011,Vol.39, No. 12Figure 1. Design and implementation of Rnt1p switches as post-transcriptional genetic control elements. (A) The design of an Rnt1p switch (RS) by
the integration of a sensor component ( TCT-4 aptamer) into the actuator component (R31L-3B4Inv Rnt1p hairpin). R31L-3B4Inv contains the
consensus regions of a Rnt1p substrate: the CEB, BSB and IBPB. The nucleotide modiﬁcations associated with the Rnt1p and ligand-binding
controls (RSN and RSnt, respectively) are indicated on RS. Color scheme is as follows: CEB and aptamer, red; BSB, blue; IBPB, green. Black
triangles indicate locations of cleavage sites by Rnt1p. The regulatory activity of the synthetic Rnt1p switches is a function of the modular elements
in the BSB and CEB/aptamer, which are indicated by the dashed boxes on RS. (B) The synthetic Rnt1p switches control the destabilization of target
transcripts by controlling Rnt1p cleavage in the 30-UTR of transcripts encoding a gene of interest (goi). Barrels represent protein molecules and dark
blue circles represent the ligand molecule. In the absence of ligand binding to the aptamer module, the transcript is inactivated by Rnt1p cleavage
and translation inhibited. Ligand binding to the aptamer module in the CEB inhibits Rnt1p cleavage activity and stabilizes the transcript, resultingi n
increased protein production. (C) The dose–response curves of RS and the Rnt1p and ligand-binding controls, RSN and RSnt, respectively, indicate
that decreased gene expression is caused by Rnt1p cleavage and that cleavage is inhibited by theophylline. The following concentrations of theo-
phylline are used for all response curves (in mM): 0, 0.05, 0.2, 0.5, 2, 5. Normalized protein levels were determined by measuring the median GFP
levels from cells harboring constructs with the indicated switch through ﬂow cytometry analysis, and values are reported relative to a construct
lacking a hairpin module (set to 100%). Solid curves indicate the theoretically-determined model ﬁt. The model parameters for the curve ﬁt are
provided in Table 1. Dashed curves are utilized for control constructs that are not ﬁt to the model and are generated through Microsoft Excel’s
smooth line option. (D) Analysis of transcript levels of the Rnt1p switch, RS and the controls, RSN and RSnt, supports the proposed mechanism of
inhibition of Rnt1p processing due to ligand binding. Relative transcript levels are determined by measuring transcript levels of yEGFP3 and a
house-keeping gene, ACT1, through qRT-PCR and normalizing the yEGFP3 levels with their corresponding ACT1 levels. Normalized transcript
levels for each construct are reported relative to that from an identical construct lacking a hairpin module. (E) Cleavage reaction assays and analyzes
by denaturing polyacrylamide gel electrophoresis on the Rnt1p switch RS and the controls, RSnt and RSN, support the proposed mechanism of
inhibition of Rnt1p processing due to ligand binding. The top band corresponds to uncleaved full-length RNA; the bottom bands correspond to the
three cleavage products expected from Rnt1p processing. Two of the expected cleavage products differ in size by 2nt and cannot be resolved into
individual bands under the conditions used for this assay. RNA was added to the ﬁnal concentration of 0.05mM in each reaction. When present,
Rnt1p was added to the ﬁnal concentration of 20.7mM and theophylline was added to the ﬁnal concentration of 10mM.
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theophylline concentrations increase from 0 to 5mM, re-
sulting in a fold-change of 1.93 and a dynamic range of
44% (Table 1). The EC50 value for RS was determined to
be 0.54mM, where previous studies have indicated a sub-
stantial drop in theophylline across the cell membrane
ranging from  300- to 1500-fold (18,30) (Liang, J.C.,
Michener, J.K. and Smolke, C.D., unpublished results,
2008). To verify that the reduced gene expression levels
from RS were due to Rnt1p cleavage and that the
theophylline-dependent response was due to the integrated
aptamer sequence, we characterized two control hairpins:
RSN, containing a mutant CAUC tetraloop that had been
previously shown to impede Rnt1p activity in vivo (20),
and RSnt, containing a single nucleotide mutation in the
theophylline aptamer that obstructs the associated
ligand-binding activity. The dose–response curve of RSN
demonstrates gene expression levels at or around 100%
for all theophylline concentrations, whereas the dose–
response curve of RSnt demonstrates a consistent level
of reduced gene expression independent of theophylline
(Figure 1C).
Rnt1p processing is expected to destabilize the tran-
script and thus reduce transcript levels. We monitored
relative steady-state transcript levels of RS and its
controls, RSN and RSnt, in the presence and absence of
ligand by qRT-PCR and conﬁrmed that decreased tran-
script levels are associated with decreased protein expres-
sion (Figure 1D). In order to further verify the
competition between ligand-binding and Rnt1p cleavage,
we performed in vitro cleavage assays with puriﬁed Rnt1p
and radiolabeled Rnt1p substrates in the presence and
absence of theophylline (Figure 1E). We observed no
Rnt1p activity on the mutated tetraloop control (RSN)
and the inability of theophylline to impact Rnt1p
activity with the inactive aptamer control (RSnt). In
contrast, Rnt1p was able to cleave the switch (RS) in the
absence of theophylline, but that activity was inhibited
when theophylline was added. We also performed identi-
cal reactions without Rnt1p to examine any non-speciﬁc
effects of theophylline on the Rnt1p substrates, which con-
ﬁrmed that theophylline has no effect on how the RNA
runs in the gel (Figure 1E). Taken together, the results
indicate that the knock down in expression levels and
the theophylline response exhibited by RS are due to
Rnt1p cleavage and ligand binding to the integrated
aptamer, respectively.
Replacement of the aptamer sequence modulates ligand
responsiveness and Rnt1p processing
The response curve of the Rnt1p switch can be modulated
by three parameters associated with the genetic device: the
strength of the ligand–aptamer interaction, the binding
afﬁnity of Rnt1p for the hairpin and the cleavage rate of
Rnt1p on the hairpin. The ligand–aptamer interaction will
primarily affect the EC50 of the dose–response curve,
where aptamers with stronger afﬁnities (lower KD
values) will result in decreased EC50 values. However,
modiﬁcations that result in stronger interactions between
the hairpin and Rnt1p will result in increased EC50 values.
Finally, modiﬁcations to the cleavage rate of Rnt1p on the
hairpin will result in changes to the dynamic range or
fold-change of the switch based on Michaelis–Menten
enzyme kinetics, where increased Rnt1p activity corres-
ponds to an increase in Vmax resulting in a lowering of
the baseline in the absence of theophylline. The two
regions of an Rnt1p hairpin that can be experimentally
altered to achieve these affects are the CEB (or integrated
aptamer sequence) and the Rnt1p binding regions (BSB
and IBPB). We ﬁrst examined the ability to modulate the
EC50 value associated with the Rnt1p switch by
incorporating aptamers with different ligand afﬁnities.
However, because the aptamer sequence is located
within the CEB there may be unpredicted effects of
integrating alternative aptamer sequences on the Rnt1p
processing rates.
Table 1. Relevant parameters for all RS-based switches and the Rnt1p and ligand-binding controls, RSN and RSnt
Switch EC50 (mM) b=Y (0mM) % Y (5mM) % Fold-change Dynamic range % M%
RS 0.54±0.05 47±2 91±3 1.93±0.10 44±4 97±1
RSN 98±3 101±5 1.03±0.06 3±6
RSnt 49±2 59±2 1.20±0.07 10±3
RS-theo2 1.47±0.30 52±2 84±2 1.60±0.06 32±3 94±3
RS-theo3 1.17±0.09 41±4 101±4 2.47±0.26 60±6 116±2
RS-B03 0.48±0.08 79±4 102±4 1.29±0.08 23±5 105±1
RS-B05 0.56±0.07 51±1 97±4 1.91±0.10 46±4 104±2
RS-B06 0.59±0.11 56±5 101±6 1.82±0.19 46±7 108±3
RS-B07 0.84±0.04 44±2 100±4 2.30±0.13 57±5 110±1
RS-B12 0.47±0.08 44±2 94±4 2.11±0.12 50±4 99±2
RS 2 1.07±0.02 20±1 79±3 3.91±0.19 59±3 92±0
RS 3 1.81±0.06 10±0 57±1 5.57±0.26 47±1 74±1
RS-B07 2 1.81±0.11 16±1 69±4 4.24±0.36 53±4 89±2
RS-B12 2 0.89±0.07 22±0 73±1 3.30±0.08 51±1 81±2
RS-theo3-B07 1.13±0.10 37±2 91±2 2.47±0.14 54±3 103±2
RS-theo3-B12 1.14±0.13 36±1 84±1 2.31±0.09 48±2 95±2
b and Y (5mM) are experimentally determined values corresponding to the normalized protein levels at 0mM and 5mM theophylline, respectively.
The EC50 and theoretical maximal output (M) are parameters determined by ﬁtting the dose-response data to the binding model. The fold-change is
the ratio of Y (5mM) to b and the dynamic range is the difference between these two values. The theoretical fold-change and dynamic range
determined by M instead of Y (5mM) are reported in Supplementary Table S2.
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alternative theophylline aptamer sequences:  -33
(RS-theo2) and a  TCT-4 variant (RS-theo3) (29)
(Figure 2A). The  -33 aptamer (KD=0.32mM) exhibits
a slightly decreased afﬁnity relative to the  TCT-4
aptamer (KD=0.29mM) (29). However, the effect of the
varied aptamer sequences on the switch-response curve
was unknown, as aptamer integration required removal
of terminal loops and different numbers of base-pairs at
the base of the switch, which have been shown to affect the
KD of the aptamer (29), and required nucleotide modiﬁ-
cations of the hairpin stem, which have been shown to
affect both Rnt1p binding and cleavage (27). The EC50
values of RS-theo2 (1.47mM) and RS-theo3 (0.83mM)
were greater than that exhibited by RS (0.54mM), and
both switches exhibited changes in the baseline expression
levels of the dose-response curves (Figure 2B and Table 1).
The increased EC50 values for both switches indicate that
the aptamer modiﬁcations decreased ligand afﬁnity. In
terms of Rnt1p cleavage, RS-theo2 exhibited decreased
Rnt1p processing and RS-theo3 exhibited increased pro-
cessing as determined from the baseline levels in the
absence of ligand (RS: 47%; RS-theo2: 52%; RS-theo3:
42%). Therefore, RS-theo3 exhibited a larger dynamic
range (DR) and fold-change (fold) than RS (RS-theo3:
51% DR, 2.21 fold; RS: 44% DR, 1.93 fold), although
its EC50 value was  50% greater than that of RS,
whereas RS-theo2 exhibited a decreased dynamic range
and fold-change (RS-theo2: 32% DR, 1.60 fold). These
results indicate that the sequence and structure of
aptamer components, in addition to their binding
properties, can impact the regulatory range exhibited by
Rnt1p switches.
Incorporation of synthetic BSBs modulates ligand
responsiveness and processing of the Rnt1p switch
Modiﬁcations to the binding region of the Rnt1p hairpin
can also be used to tune the switch response. A set of
synthetic BSB modules was previously described (A.H.
Babiskin and C.D. Smolke, submitted for publication),
which can be used to modulate Rnt1p binding afﬁnities.
However, the synthetic BSB modules were shown to affect
Rnt1p binding and processing (A.H. Babiskin and C.D.
Smolke, submitted for publication), such that changes in
both the EC50 value and baseline expression level of the
dose-response curve are expected from their integration
into the Rnt1p switch.
We incorporated several synthetic BSB modules (B03,
B05, B06, B07, B12) into the BSB of RS (Figure 3A,
Supplementary Table S3). We observed a shift in the
baseline expression levels for the dose-response curves of
all BSB-modiﬁed Rnt1p switches, where expression levels
at 5mM theophylline were restored to  90–100%
normalized protein levels (Figure 3B, Table 1,
Supplementary Figure S3). The primary effect of the
incorporated BSBs was observed with shifts in the
baseline levels, which were likely a result of altered pro-
cessing rates by Rnt1p. Two of the switches, RS-B07 and
RS-B12, exhibited decreases in the baseline expression
levels (44%) relative to RS (47%), thereby resulting in
an increased dynamic range and fold-change (RS-B07:
57% DR, 2.30 fold; RS-B12: 50% DR, 2.11 fold; RS:
44% DR, 1.93 fold). The remainder of the switches ex-
hibited increases in the baseline levels, resulting in slightly
reduced or similar dynamic range and fold-change
(Table 1). The majority of the modiﬁed BSB Rnt1p
switches exhibited slight shifts in the EC50 values (from
0.48 to 0.59mM). However, RS-B07 exhibited a substan-
tially higher EC50 value of 0.81mM. The improvement in
switch activity for RS-B07 and RS-B12 as determined by
the fold-change was due to the increased processing by
Rnt1p. However, RS-B12 exhibited greater sensitivity to
lower concentrations of theophylline relative to RS-B07 as
determined by the EC50 values for these switches
(RS-B12: 0.58mM; RS-B07: 0.81mM). These results
indicate that the set of synthetic BSB modules can be
employed to tune the baseline expression exhibited by
Rnt1p switches while maintaining restoration of the
‘ON’ state.
Figure 2. Tuning the response curve of the Rnt1p switch through the integration of different theophylline aptamers. (A) Switch and aptamer module
sequences illustrating the replacement of the aptamer sequence in RS with different theophylline aptamers: theo2 and theo3. Gray lettering is used
to indicate the nucleotides in theo2 and theo3 that differ from theo1. (B) The dose–response curves of RS, RS-theo2 and RS-theo3 indicate a shift
in EC50 values and variations in the baseline levels. Data are reported as indicated in Figure 1C. The model parameters for the curve ﬁt are provided
in Table 1.
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theophylline responsiveness and increases fold-change
We examined a third tuning strategy for the Rnt1p switch
regulatory response based on integrating multiple copies
of a switch in the 30-UTR of a target transcript. The inte-
gration of multiple copies of cis-acting RNA switches in
the 30-UTR of target transcripts has previously been
demonstrated to modulate the regulatory response by
decreasing baseline expression levels (11,31). However, it
is also expected that this tuning strategy will result in
decreased sensitivity to the ligand or an increased EC50
value for a given regulatory system. Based on a mechan-
ism of competition inhibition, we anticipated that the RS
switch design would demonstrate close to full restoration
of gene activity under maximal ligand concentrations, re-
sulting in signiﬁcant increases in the fold-change and
dynamic range of the system.
We built two-copy (RS 2) and three-copy (RS 3) RS
switch constructs (Figure 4A). We observed an increase
in the EC50 value and a decrease in baseline expression
levels with increasing switch copy number (Figure 4B and
Table 1). The effect of multiple Rnt1p switches on the
EC50 value of the system was determined to be nearly
additive. However, the effect of multiple switches on the
baseline level (b) was determined to be multiplicative:
bx ¼ð b1Þ
x ¼ð 47%Þ
x
Where x is the number of modules. At the highest concen-
tration of theophylline added to the system (5mM), the
gene expression levels decreased with increasing switch
number. We expected the ON state expression levels to
be multiplicative with the theoretical maximal state (M)
(Supplemental Table S2); while this relationship was
observed for RS 2, it was not observed for RS 3. With
three copies of RS, the full switch dynamic range cannot
be observed when limited to 5mM theophylline, as
evidenced by the lack of saturation of the dose-response
curve. The fold-change of the system increased with
increasing switch number from 1.93 (RS) to 3.91 (RS 2)
to 5.57 (RS 3). We veriﬁed that the observed trends in
protein expression were consistent with transcript levels,
supporting increased Rnt1p processing of the multiple
switch modules (Figure 4C). Based on the observed
trends, we expect that we would likely observe a
decrease in regulatory activity when over three copies of
the Rnt1p switch are implemented, as further decreases in
baseline levels would be limited and the EC50 value would
be well above 2mM theophylline, thus substantially
limiting the ON state expression levels that could be
accessed. These results indicate that the integration of
multiple switch copies can be used to predictably tune
the dynamic range and EC50 value exhibited by a given
Rnt1p switch.
Combined tuning strategies support the rational design of
Rnt1p switch control systems with enhanced regulatory
properties
Our studies identiﬁed three different strategies for tuning
the regulatory response of an Rnt1p switch based on
altering the aptamer/CEB, BSB and number of switch
modules. We propose that these tuning modules can be
combined to rationally design Rnt1p switches with
enhanced regulatory properties. We ﬁrst examined the
combined implementation of synthetic BSB modules
with multiple copies of the modiﬁed Rnt1p switches. We
built genetic control systems that contained two copies of
Rnt1p switches incorporating the BSB modules that
resulted in the largest single-copy switch dynamic ranges
(RS-B07, RS-B12). Both two-copy switch systems
(RS-B07 2, RS-B12 2) exhibited decreased baseline ex-
pression levels that followed the previously described
multiplicative trends (Figure 5A and Table 1). Although
both switches exhibited the expected increased dependence
Figure 3. Tuning the response curve of the Rnt1p switch through the integration of different synthetic BSB modules. (A) Switch and BSB module
sequences illustrating the replacement of the BSB sequence with synthetic BSB modules (B03, B05, B06, B07 and B12). The gene-regulatory activities
of the synthetic BSB modules as previously determined in the context of an Rnt1p hairpin control element are provided in Supplementary Figure S3.
(B) The dose–response curves of RS, RS-B07 and RS-B12 indicate that the two synthetic BSB modules decrease baseline levels and exhibit minor
effects on the EC50 of the response curve. The dose–response curves of the other BSB-incorporated switches are presented in Supplementary Figure
S3. Data are reported as indicated in Figure 1C. The model parameters for the curve ﬁt are provided in Table 1.
5306 Nucleic Acids Research, 2011,Vol.39, No. 12on theophylline, the EC50 values were not additive as had
been observed with RS. Limitations in theophylline con-
centration had a more substantial impact on the experi-
mentally attainable dynamic range of RS-B07 2
compared with that of RS 2, as RS-B07 2 exhibits an
EC50 value that is nearly twice that of RS 2. Even with
this limitation, RS-B07 2 exhibits a larger fold-change
than that of RS 2. However, the theoretical fold-change
[based on the theoretical maximal output of the switch
(M) from the model ﬁt] of RS-B07 2 increases from
4.24 to 5.42, whereas that of RS 2 only increases to
4.54. RS-B12 experienced the lowest level of gene expres-
sion in its ON state (at 5mM theophylline and M) when
compared with the other switches incorporating synthetic
BSB modules (Table 1, Supplementary Table S2).
Therefore, due to the multiplicative effect associated
with multiple switch modules, we expected the ON state
for RS-B12 2 to be diminished greater than the other two
module switches. Although the baseline was reduced
multiplicatively for RS-B12 2 and the theoretical
fold-change enhanced, the decrease to the ON state
resulted in smaller improvements in the fold-change
relative to RS 2 and RS-B07 2 from their respective
single module switch.
We next examined the combined implementation of
synthetic BSB modules with alternative aptamer modules
to improve Rnt1p switch regulatory range. We identiﬁed
two synthetic BSB modules (B07, B12) and one alternative
aptamer module (theo3) that resulted in increases in
dynamic range and fold-change when integrated individu-
ally into the Rnt1p switch platform. Therefore, we
designed two new Rnt1p switches that combined these
modules: RS-theo3-B07 and RS-theo3-B12 (Figure 5B).
The combined module switches exhibited changes in
EC50 values and dynamic ranges that were improved
from the effects of the individual tuning modules (Figure
5C and Table 1). Speciﬁcally, RS-theo3-B07 and
RS-theo3-B12 exhibited increased EC50 values (1.13 and
1.14mM, respectively) from those exhibited by RS-theo3
(0.83mM), RS-B07 (0.81mM) and RS-B12 (0.58mM). In
addition, both RS-theo3-B07 and RS-theo3-B12 exhibit
baseline levels (37% and 36%, respectively) that are
lower than the switches harboring the individual tuning
modules (RS-theo3: 42%; RS-B07 and RS-B12: 44%)
(Figure 5C). The rationally tuned Rnt1p switches,
RS-theo3-B07 and RS-theo3-B12, exhibit the greatest
fold-change of the single-copy switches generated in this
study (RS-theo3-B07: 2.47; RS-theo3-B12: 2.31). The
results demonstrate that the rational combination of inde-
pendent tuning modules can be used to improve switch
regulatory ranges in a manner that is predictable from
the individual module effects.
DISCUSSION
We have developed a new class of synthetic RNA devices
based on ligand-responsive modulation of RNase III
cleavage activity in S. cerevisiae. Our design strategy
incorporated a sensor component, encoded within an
aptamer sequence, directly within a region of Rnt1p sub-
strates known to effect enzyme cleavage—the CEB. This
direct integration design strategy differs from commonly
Figure 4. Predictive tuning of the Rnt1p switch-response curve through the integration of multiple copies of the switch module. (A) Schematic
representing the integration of multiple switch modules. Each Rnt1p switch is insulated with spacer sequences as indicated in Figure 1A. Two and
three copies of the original RS switch were examined for their effects on the regulatory response. (B) The dose–response curves of RS, RS 2 and
RS 3 indicate increasing dependence on theophylline concentration and decreasing baseline levels with each added switch module. Data are reported
as indicated in Figure 1C. The model parameters for the curve ﬁt are provided in Table 1. (C) The transcript levels of RS, RS 2 and RS 3 support
increased Rnt1p processing of the multiple switch modules. Data are reported as indicated in Figure 1D.
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that couple the aptamer component to the regulatory
component through a linker sequence (5,32,33). As such
the Rnt1p switch does not undergo substantial secondary
structure rearrangements between gene-regulatory active
and inactive states as is observed with many RNA
switch platforms, but instead functions through inhibiting
Rnt1p processing as a result of the slight structural
changes or sequestering of CEB nucleotides associated
with ligand binding at the aptamer/CEB domain. A
similar direct integration design strategy was recently
described for a synthetic RNA switch platform based on
modulating Drosha (an RNase III enzyme in the RNAi
pathway) processing of its substrates by integration of
aptamer sequences into the basal segment region of
pri-miRNA hairpins (19). In addition, a direct coupling
strategy was previously described for the design of an
RNA switch that modulated Dicer (another RNase III
enzyme in the RNAi pathway) processing of shRNA sub-
strates by coupling aptamer sequences to the terminal loop
of the shRNA hairpin (17). These examples indicate that
the direct integration of sensor and actuator components
may present an effective design strategy for riboswitches
based on the modulation of RNase III processing
activities.
We had previously demonstrated that the CEB region
has no rigid structural or sequence requirements for efﬁ-
cient Rnt1p cleavage (20). Therefore, the described Rnt1p
switch platform is likely amenable to diverse aptamer se-
quences, supporting the ability to tailor Rnt1p switches to
diverse molecular effectors. However, our earlier work
also demonstrated that different nucleotide sequences in
the CEB resulted in altered processing rates by Rnt1p
in vivo (20). Therefore, it is also expected that changing
the aptamer sequence within the CEB will result in unpre-
dictable changes to the baseline levels exhibited by the
switch due to effects of the aptamer sequence on Rnt1p
cleavage activity. This was observed when integrating dif-
ferent theophylline aptamer sequences into the Rnt1p
switch platform (Figure 2B and Table 1). Ultimately, the
Figure 5. Combinatorial implementation of multiple tuning modules results in predictive tuning of the Rnt1p switch regulatory response curve.
(A) The dose–response curves of switches that incorporate synthetic BSB and multiple switch modules (RS-B07, RS-B12, RS-B07 2 and RS-B12 2)
indicate increased dependence on theophylline concentration and decreased baseline levels based on the combined activity of the two incorporated
tuning modules. The model parameters for the curve ﬁt are provided in Table 1. (B) Optimization of single-copy switch designs by incorporating
synthetic BSB modules (B07 and B12) with the aptamer/CEB module (theo3) that exhibited the most improved switch-response curves. (C) The dose–
response curves of RS3-theo3, RS-theo3-B07 and RS-theo3-B12 indicate that integration of optimized BSB and aptamer/CEB modules results in
Rnt1p switches exhibiting improved dynamic range and fold-change over that observed with the individual modules. Data are reported as indicated
in Figure 1C. The model parameters for the curve ﬁt are provided in Table 1.
5308 Nucleic Acids Research, 2011,Vol.39, No. 12activity of an Rnt1p switch will be determined by two
factors: (i) the ability of the aptamer sequence and struc-
ture to be effectively processed by Rnt1p; and (ii) the
ability of the ligand to compete with Rnt1p binding and
cleavage or decrease Rnt1p’s ability to cleave the
ligand-bound CEB. For example, in our initial studies
we examined different placements of the theophylline
aptamer in the Rnt1p hairpin stem and observed several
designs that were processed efﬁciently by Rnt1p, but
where Rnt1p activity was not inhibited under ligand
addition (data not shown). It is likely that the sequences
and structures of certain aptamers will inhibit Rnt1p
cleavage activity when placed in the CEB. Therefore, the
successful design of Rnt1p switches responsive to new
effector molecules will likely require screening of potential
aptamer sequences within the switch platform for those
sequences and structures that can be effectively cleaved
by Rnt1p. In addition, newer in vivo screening methods
will likely be effective in identifying the best aptamer can-
didates from in vitro enriched aptamer pools (34).
Optimization of the Rnt1p switch regulatory response
was signiﬁcantly aided by earlier foundational work con-
ducted in our laboratory on developing synthetic CEB and
BSB modules that can be implemented individually or in
combination to rationally build tailored Rnt1p control
elements (20; A.H. Babiskin and C.D. Smolke, submitted
for publication). We demonstrated that synthetic BSB
modules from a set of 16 previously described elements
(A.H. Babiskin, and C.D. Smolke, submitted for
publication) can be integrated into an Rnt1p switch to
tune switch dynamics by modulating the baseline expres-
sion. Using this approach we identiﬁed two synthetic BSB
modules (B07 and B12) that increase the dynamic range
and fold-change of the switch response. However, it was
also observed that the rank-order activities of the BSB
modules as previously characterized in the Rnt1p
hairpin substrate were different than that observed in
the Rnt1p switch hairpin (RS) as determined by the
baseline level in the absence of theophylline. This differ-
ence is likely due to the fact that the intervening stem
between the CEB and BSB modules are different in the
original Rnt1p hairpin substrate and the hairpin used for
the Rnt1p switch. In addition, the aptamer sequence
integrated into the CEB region also extends beyond the
CEB module, introducing additional changes to that stem
region. Therefore, the data indicate that the relative
activities of the BSB elements may be affected by the
stem sequence between the CEB and BSB modules.
We also demonstrated that the different tuning modules
can be implemented combinatorially to predictably tailor
the switch-response curve based on the individual
activities of each module. For example, by integrating
the BSB modules (B07 and B12) with the aptamer/CEB
module (theo3) that most improved the switch-response
curve into a single Rnt1p switch, we were able to build
single-copy switches exhibiting a greater dynamic range,
fold-change and lowered baseline expression level than
any of the switches harboring one of these modules
(Figure 5C and Table 1). However, as one drawback of
this tuning strategy, modules that improved the switching
activity of the response curve generally also resulted in
increased EC50 values. This trade-off between switching
activity and sensitivity highlights the requirement for de-
veloping higher afﬁnity aptamers or aptamers with
appropriate afﬁnities for the intended application (35).
A third tuning strategy was examined to improve
switching activity based on the implementation of
multiple copies of Rnt1p switches in a single target tran-
script. Two-copy switch systems were examined for the
original Rnt1p switch (RS) and two BSB-tuned switches
that exhibited improved regulatory responses (RS-B07
and RS-B17). In general, the implementation of a
second copy of a given switch resulted in decreased
baseline levels, increased fold-change, and increased
EC50 values (Figure 4B, Figure 5A and Table 1), where
the observed effects on baseline levels were multiplicative.
However, the observed dynamic range (difference between
the ON and the OFF states) did not increase with
increasing switch number, due to the response curves
not saturating at 5mM theophylline. In addition, the
maximal ON state (M), determined by extrapolating
the data with the binding model curve ﬁt, indicated that
the theoretical dynamic range only slightly increased for
RS-B07 2 and RS-B17 2 (Supplementary Table S2).
This limited improvement in theoretical dynamic range
was due to substantial decreases in M with increasing
switch number, potentially due to non-speciﬁc effects re-
sulting from the additional structures such as interference
with translation or transcript destabilization or due to
increased residual cleavage by Rnt1p of the substrate in
the ligand-bound form. We also built a three-copy version
of RS (RS 3), which exhibited additional increases in the
fold-change over the two-copy system. However, the im-
plementation of three Rnt1p switch modules exhibited
limiting returns in the decreased baseline levels and
increased the EC50 of the response curve to a level ap-
proaching that which would not allow proper observation
of switch activity due to limitations in theophylline con-
centrations that can be applied to the yeast culture.
This work extends the utility of Rnt1p control elements
for cellular engineering applications by developing an
integrated RNA platform for building ligand-responsive
Rnt1p-based control devices in yeast. By taking a synthet-
ic biology approach to the development of a tool for de-
signing precise genetic control elements based on building
Rnt1p controllers from synthetic modules (20; A.H.
Babiskin and C.D. Smolke, submitted for publication),
we were able to identify readily implementable tuning
and optimization strategies for the more complex Rnt1p-
based regulatory device. Speciﬁcally, we demonstrated
that three tuning strategies, based on the implementation
of synthetic aptamer/CEB, BSB and switch modules inde-
pendently or in combination, can be used to optimize the
regulatory response of the engineered control system.
Importantly, the effects of the tuning modules when im-
plemented combinatorially were predictable from their in-
dividual activities. An interesting aspect of this engineered
riboswitch platform is that our single-copy switches gen-
erally exhibit fully restored gene expression activity at
maximum ligand concentration compared to constructs
lacking a switch, such that the observed differences
Nucleic Acids Research, 2011,Vol.39, No. 12 5309between switch activities are largely due to changes in
baseline levels.
An advantage of such RNA devices over traditional
genetic control elements, such as those based on
promoter systems, is the ability to tune regulatory
activities to match application-speciﬁc requirements and
to tailor the input processing and output gene-regulatory
functions of these devices. In addition, because they act
post-transcriptionally, RNA devices can be coupled with
any promoter of interest, allowing researchers to build
layered control schemes and thus more sophisticated
genetic networks. While the Rnt1p switches exhibit rela-
tively moderate gene-regulatory activities (in terms of
fold-change), recent research has demonstrated the appli-
cation of other engineered RNA controllers exhibiting
similar activities to the regulation of diverse cellular
phenotypes (11,12,34,36). Therefore, the integration of
compatible aptamers into this switch platform that
respond to broad classes of molecules of interest,
including non-toxic exogenous chemicals, primary metab-
olites and chemicals of industrial interest, will advance the
engineering of genetic circuits in yeast for diverse biotech-
nological applications.
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